JPS6474990A - Vector, recombinant dna, virus and production of protein - Google Patents
Vector, recombinant dna, virus and production of proteinInfo
- Publication number
- JPS6474990A JPS6474990A JP62231107A JP23110787A JPS6474990A JP S6474990 A JPS6474990 A JP S6474990A JP 62231107 A JP62231107 A JP 62231107A JP 23110787 A JP23110787 A JP 23110787A JP S6474990 A JPS6474990 A JP S6474990A
- Authority
- JP
- Japan
- Prior art keywords
- gene
- nuclear
- protein
- virus
- recombinant dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PURPOSE:To mass produce HIV antigen protein, by integrating a manifestation vector of DNA of nuclear polyhedroisis virus of silkworm with a gene of HIV antigen active protein and using the prepared recombinant DNA. CONSTITUTION:A gene of gag, pol, SOR gp120 or gp41 of HIV is integrated into a polylinker range of transfer vector pBFs containing a promoter range of a polyhedron protein structure gene of DNA of nuclear polyhedroisis virus silkworm to construct recombinant DNA. A recombinant nuclear polyhedroisis virus infected with the recombinant DNA is multiplied nuclear in a culture cell or host to give a large amount of HIV antigen protein. Plasmid pBFs can be constructed from plasmid pBmE36 containing EcoRI-EcoRI fragment of polyhedron gene of silkworm, contains ATG code, a signal of a protein synthesis initiator of nuclear polyhedron gene and has a polylinker and a termination codon TAA of polyhedron gene after the ATG code.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62231107A JPS6474990A (en) | 1987-09-17 | 1987-09-17 | Vector, recombinant dna, virus and production of protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62231107A JPS6474990A (en) | 1987-09-17 | 1987-09-17 | Vector, recombinant dna, virus and production of protein |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6474990A true JPS6474990A (en) | 1989-03-20 |
Family
ID=16918409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62231107A Pending JPS6474990A (en) | 1987-09-17 | 1987-09-17 | Vector, recombinant dna, virus and production of protein |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6474990A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS619288A (en) * | 1984-06-21 | 1986-01-16 | Dai Ichi Seiyaku Co Ltd | Preparation of peptide |
JPS61173782A (en) * | 1984-10-31 | 1986-08-05 | カイロン・コーポレイション | Recombinant virus protein relating to lymph node disease syndrome and/or acquired immunodeficient syndrome |
-
1987
- 1987-09-17 JP JP62231107A patent/JPS6474990A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS619288A (en) * | 1984-06-21 | 1986-01-16 | Dai Ichi Seiyaku Co Ltd | Preparation of peptide |
JPS61173782A (en) * | 1984-10-31 | 1986-08-05 | カイロン・コーポレイション | Recombinant virus protein relating to lymph node disease syndrome and/or acquired immunodeficient syndrome |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Accola et al. | Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6 gag | |
Borsetti et al. | The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly | |
Mochizuki et al. | An infectious DNA clone of HIV type 1 subtype C | |
IE800991L (en) | HBs Ag GENE AND PRODUCT | |
WO2001081608A3 (en) | Viral vectors for use in monitoring hiv drug resistance | |
ATE291632T1 (en) | LENTIVIRUS-BASED GENE TRANSFER VECTORS | |
EP0265785A3 (en) | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells | |
CA2370103A1 (en) | Method and means for producing high titer, safe, recombinant lentivirus vectors | |
ES8706208A1 (en) | Expression of immunologically reactive viral proteins. | |
AU588462B2 (en) | Non-cytopathic clone of human t-cell lymphotropic virus type iii | |
Deora et al. | Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation | |
Santra et al. | Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors | |
CN101353666B (en) | HIV medicament screening cell model and special pseudotype lentivirus therefor | |
Pancio et al. | Human immunodeficiency virus type 2 Vpx-Gag interaction | |
Digilio et al. | The simian T-lymphotropic/leukemia virus from Pan paniscus belongs to the type 2 family and infects Asian macaques | |
JPS6474990A (en) | Vector, recombinant dna, virus and production of protein | |
Gupta et al. | Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon | |
FR2607518B1 (en) | VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN P25 OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A., INFECTED CELL CULTURE, PROTEIN OBTAINED, VACCINE AND ANTIBODIES OBTAINED | |
Burns et al. | Purification and secondary structure determination of simian immunodeficiency virus p27. | |
EP1246913A2 (en) | Molecular clones with mutated hiv gag/pol, siv gag and siv env genes | |
CA2330618A1 (en) | Viral chimeras comprised of caev and hiv-1 genetic elements | |
Akahata et al. | DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particles | |
Gupta et al. | Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p17 of B-and C-subtypes | |
Ebenbichler et al. | Sera from HIV-1 infected individuals in all stages of disease preferentially recognize the V3 loop of the prototypic macrophage-tropic glycoprotein gp120 ADA | |
Liu et al. | Expression of the Extracellular Domain of the Human Immunodeficiency Virus Type 1 Envelope Protein and its Fusion with β-galactosidase in Saccharomyces cerevisiae |